Literature DB >> 12217424

Cardiovascular effects of urotensin II in different brain areas.

Yang Lu1, Chang-Jiang Zou, Da-Wei Huang, Chao-Shu Tang.   

Abstract

It has been shown that intracerebroventricular injection of urotensin II (UII)-induced hypotensive and bradycardiac responses. Here, we tested the cardiovascular roles of UII in different brain areas by microinjection of UII into the A1 and A2 areas (noradrenergic cells found in the lower part of the medulla that have been designated either A1 or A2 areas), the paraventricular and the arcuate nucleus. In urethane-anaesthetized rats, we observed that: (1) microinjection of UII into the A1 area induced dose-related depressor and bradycardiac responses; (2) mean arterial blood pressure (mABP) and heart rate (HR) did not change significantly after microinjection of UII into the A2 area; and (3) significant increases in mABP and HR were induced after microinjection of 10 pmol UII into either the paraventricular or arcuate nucleus. The above results suggest that UII, in different brain areas, plays different roles in cardiovascular regulation and the A1 area is a very important action site for UII in cardiovascular regulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12217424     DOI: 10.1016/s0196-9781(02)00104-3

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  10 in total

Review 1.  The role of urotensin II in cardiovascular and renal physiology and diseases.

Authors:  Yi-Chun Zhu; Yi-Zhun Zhu; Philip Keith Moore
Journal:  Br J Pharmacol       Date:  2006-06-19       Impact factor: 8.739

Review 2.  A rat brain atlas of urotensin-II receptor expression and a review of central urotensin-II effects.

Authors:  Benjamin D Hunt; Leong L Ng; David G Lambert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-04-27       Impact factor: 3.000

3.  Behavioral effects of urotensin-II centrally administered in mice.

Authors:  Jean-Claude Do-Rego; David Chatenet; Marie-Hélène Orta; Bertrand Naudin; Camille Le Cudennec; Jérôme Leprince; Elizabeth Scalbert; Hubert Vaudry; Jean Costentin
Journal:  Psychopharmacology (Berl)       Date:  2005-10-22       Impact factor: 4.530

4.  Urotensin II promotes vagal-mediated bradycardia by activating cardiac-projecting parasympathetic neurons of nucleus ambiguus.

Authors:  Gabriela Cristina Brailoiu; Elena Deliu; Joseph E Rabinowitz; Douglas G Tilley; Walter J Koch; Eugen Brailoiu
Journal:  J Neurochem       Date:  2014-03-06       Impact factor: 5.372

5.  Deletion of the UT receptor gene results in the selective loss of urotensin-II contractile activity in aortae isolated from UT receptor knockout mice.

Authors:  David J Behm; Stephen M Harrison; Zhaohui Ao; Kristeen Maniscalco; Susan J Pickering; Evelyn V Grau; Tina N Woods; Robert W Coatney; Christopher P A Doe; Robert N Willette; Douglas G Johns; Stephen A Douglas
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

6.  Microinjection of urotensin II into the pedunculopontine tegmentum leads to an increase in the consumption of sweet tastants.

Authors:  Robert Ettaro; Tamara Markovic; Derek Daniels; Duncan Aa MacLaren; Stewart D Clark
Journal:  Physiol Behav       Date:  2019-12-13

7.  Urotensin II modulates rapid eye movement sleep through activation of brainstem cholinergic neurons.

Authors:  Salvador Huitron-Resendiz; Morten P Kristensen; Manuel Sánchez-Alavez; Stewart D Clark; Stephen L Grupke; Christopher Tyler; Chisa Suzuki; Hans-Peter Nothacker; Olivier Civelli; Jose R Criado; Steven J Henriksen; Christopher S Leonard; Luis de Lecea
Journal:  J Neurosci       Date:  2005-06-08       Impact factor: 6.709

8.  Divergent cardio-ventilatory and locomotor effects of centrally and peripherally administered urotensin II and urotensin II-related peptides in trout.

Authors:  Gilmer Vanegas; Jérôme Leprince; Frédéric Lancien; Nagi Mimassi; Hubert Vaudry; Jean-Claude Le Mével
Journal:  Front Neurosci       Date:  2015-04-22       Impact factor: 4.677

Review 9.  The role of urotensin II and atherosclerotic risk factors in patients with slow coronary flow.

Authors:  Ömer Şatıroğlu; Murtaza Emre Durakoğlugil; Mustafa Çetin; Yüksel Çiçek; Turan Erdoğan; Hakan Duman
Journal:  Interv Med Appl Sci       Date:  2016-12

10.  Acute Effect of Central Administration of Urotensin II on Baroreflex and Blood Pressure in Conscious Normotensive Rabbits.

Authors:  Kyungjoon Lim; Yusuke Sata; Kristy L Jackson; Sandra L Burke; Geoffrey A Head
Journal:  Front Physiol       Date:  2017-02-23       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.